SME Times is powered by   
Search News
Just in:   • RBI clarifies forex rules for services exports and imports  • Govt encourages industry to boost India's domestic, overseas mineral supply chains  • Trump cites India's growth to press Fed on rates  • FIIs pump Rs 1,11,950 crore into Indian stock markets this month to date  • India poised for big leap in AI, semiconductor manufacturing 
Last updated: 27 Sep, 2014  

Hunter Laboratories THMB HNL enters into license agreement with Hunter Laboratories

Health Network Laboratories
   Top Stories
» FIIs pump Rs 1,11,950 crore into Indian stock markets this month to date
» Sensex jumps 898 points, Nifty closes above 25,800 as banks rally on return of foreign inflows
» Microsoft rolls out agentic AI tools, Copilot Workspaces at Ignite conference
» Nifty hits 9-month high, Bank Nifty scales record peak as market rally extends
» India-Egypt trade has potential to scale $35 billion by 2035: Assocham
PR Newswire | 26 May, 2010

ALLENTOWN and CAMPBELL: Health Network Laboratories (HNL) has entered into a license agreement with Hunter Laboratories to provide HunterHeart cardiovascular disease management program. HunterHeart offers physicians and patients sophisticated risk characterization and personalized therapy guidelines for cardiovascular disease. HNL will be performing a battery of advanced tests, offering an accompanying nutrition program, and wellness coaching. Gerry Weiss, MD, Hunter's Medical Director stated: "With appropriate risk characterization and treatment, cardiovascular disease can be prevented for many patients and MI and stroke events can be significantly reduced."

"HNL's reputation for quality, service and innovation is exceptional. Hunter is delighted to be working with HNL to reduce cardiovascular disease in PA and NJ," stated Chris Riedel, Hunter's CEO. HNL's President and CEO, David G. Beckwith Ph.D., stated that, "The HunterHeart program will assist our physicians in delivering comprehensive cardiovascular health advice to their patients, and establishes HNL as a center of excellence for preventive cardiology."

About Health Network Laboratories:
Based in Allentown, Pennsylvania, Health Network Laboratories (HNL) is a multi-regional medical laboratory with technologically advanced facilities in Pennsylvania and New Jersey. HNL serves the need of the public and health care communities performing almost 6 million clinical and pathology tests each year. HNL is consistently rated highly by physicians and clients in all areas of laboratory performance and customer satisfaction.

HNL offers a full complement of clinical laboratory and anatomic pathology services, including highly specialized esoteric testing to hospitals, physicians, long-term and assisted living facilities, businesses and government agencies. For more information, visit http://www.healthnetworklabs.com/.

About Hunter Labs, Inc.:
Hunter Laboratories is the largest locally owned and operated clinical reference laboratory in northern California. HunterHeart is one of Hunter's proprietary disease detection and management programs that are being rolled-out across the U.S. Hunter's Incelldx mRNA test for cervical cancer detection is also being introduced across the U.S. This test is the only accurate HPV method for women under 30, and has better specificity for predicting CIN2/CIN3 on biopsy. For more information, visit http://www.hunterlabs.com/.

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹96.5
₹94.8
UK Pound
₹132.25
₹128.15
Euro
₹113.6
₹109.8
Japanese Yen ₹61.3 ₹59.45
As on 03 Sep, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter